VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients

References

• Charles T., Swash M. Amyotrophic lateral sclerosis: current understanding. J Neurosci Nur 2001; 33: 245–53
   PubMedGoogle Scholar
• Wang H., Fan D., Zhang J., Zhang H., Wang X., Lu M., et al. Analysis of misdiagnosis of amyotrophic lateral sclerosis pre‐admission. Chin J Contemp Neurol Neurosurg 2005; 5: 240–3
   Google Scholar
• Haverkamp L. J., Appel V., Appel S. H. Natural history of amyotrophic lateral sclerosis in a database population. Brain 1995; 118: 707–19
   PubMed Web of Science ®Google Scholar
• Andersen P. M., Sims K. B., Xin W. W., Kiely R., O'Neill G., Ravits J., et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. ALS Other Motor Neuron Disord 2003; 4: 62–73
   PubMed Web of Science ®Google Scholar
• Tomkins J., Dempster S., Banner S. J., Cookson M. R., Shaw P. J. Screening of apendonuclease as a candidate gene for amyotrophic lateral sclerosis. NeuroReport 2000; 11: 1695–7
   PubMed Web of Science ®Google Scholar
• Veldink J. H., van den Berg L. H., Cobben J. M., Stulp R. P., De Jong J. M. B. V., Vogels O. J., et al. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic amyotrophic lateral sclerosis. Neurology 2001; 56: 749–52
   PubMed Web of Science ®Google Scholar
• Jackson M., Morrison K. E., Al‐Chalabi A., Bakker M., Leigh P. N. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: homozygous neuronal apoptosis inhibitor protein deletion in a sporadic case. Ann Neurol 1996; 39: 796–800
   PubMed Web of Science ®Google Scholar
• Giess G., Beck M., Goetz R., Nitsch R. M., Toyka K. V., Sendtner M. Potential role of the leukaemia inhibitory factor as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis. Neurology 2000; 54: 1003–5
   PubMed Web of Science ®Google Scholar
• Giess R., Holtmann B., Braga M., Grimm Y., Müller‐Myhsok B., Toyka K. V., et al. Early onset of severe familial amyotrophic lateral sclerosis with a SOD‐1 mutation: potential impact of the ciliary neurotrophic factor as a candidate modifier gene. Am J Hum Genet 2002; 70: 1277–86
   PubMed Web of Science ®Google Scholar
• Dechiara T. M., Vejsada R., Poueymirou W. T., Acheson A., Suri C., Conover J. C., et al. Mice lacking the ciliary neurotrophic factor receptor, unlike mice lacking the ciliary neurotrophic factor, exhibit profound motor neuron deficits at birth. Cell 1995; 83: 313–22
   PubMed Web of Science ®Google Scholar
• Münch C., Ebstein M., Seefried U., Zhu B., Stamm S., Landwehrmeyer G. B., et al. Alternative splicing of the 5'‐sequences of the mouse excitatory amino acid transporter 2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis. J Neurochem 2002; 82: 594–603
   Google Scholar
• Meier J., Couillard‐Després S., Jacomy H., Gravel C., Julien J. Extra neurofilament NF‐L subunits rescue motor neuron disease caused by overexpression of the human NF‐H gene in mice. J Neuropath Exp Neur 1999; 58: 1099–110
   PubMed Web of Science ®Google Scholar
• Greenway M. J., Alexander M. D., Ennis S., Traynor B. J., Corr B., Frost E., et al. A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004; 63: 1936–8
   PubMed Web of Science ®Google Scholar
• Tomkins J., Banner S. J., McDermott C. J., Shaw P. J. Mutation screening of manganese superoxide dimutase in amyotrophic lateral sclerosis. NeuroReport 2001; 12: 2319–22
   PubMed Web of Science ®Google Scholar
• Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., et al. Deletion of the hypoxia‐response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131–8
   PubMed Web of Science ®Google Scholar
• Morrison K. E. Therapies in amyotrophic lateral sclerosis – beyond riluzole. Curr Opin Pharmacol 2002; 2: 302–9
   PubMed Web of Science ®Google Scholar
• Lambrechts D., Storkebaum E., Morimoto M., Del‐Favero J., Desmet F., Marklund S. L., et al. The vascular endothelial growth factor is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motor neurons against ischaemic death. Nature Genetics 2003; 34: 383–94
   PubMed Web of Science ®Google Scholar
• Brooks B. R., Miller R. G., Swash M., Munsat T. L. E1 Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–9
   PubMed Web of Science ®Google Scholar
• Yang B., Cross D. F., Ollerenshaw M., Millward B. A., Demaine A. G. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complicat 2003; 17: 1–6
   PubMed Web of Science ®Google Scholar
• Brogan I. J., Khan N., Isaac K., Hutchinson J. A., Pravica V., Hutchinson I. V. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999; 60: 1245–9
   PubMed Web of Science ®Google Scholar
• Terry P. D., Kamel F., Umbach D. M., Lehman T. A., Hu H., Sandler D. P., et al. The vascular endothelial growth factor promoter haplotype and amyotrophic lateral sclerosis. J Neurogenet 2004; 18: 429–34
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Mechanism of angiogenesis and arteriogenesis. Nature Med 2000; 6: 389–95
   PubMed Web of Science ®Google Scholar
• Sondell M., Lundborg G., Kanje M. The vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999; 19: 5731–40
   PubMed Web of Science ®Google Scholar
• Schratzberger P., Schratzberger G., Silver M., Curry C., Kearney M., Magner M., et al. Favourable effect of the vascular endothelial growth factor gene transfer on ischaemic peripheral neuropathy. Nat Med 2000; 6: 405–13
   PubMed Web of Science ®Google Scholar
• Jin K., Zhu Y. H., Sun Y. J., Mao X. O., Xie L., Greenberg D. A. The vascular endothelial growth factor stimulates neurogenesis in vitro and in vivo. P Natl Acad Sci. USA 2002; 99: 11946–50
   PubMed Web of Science ®Google Scholar
• Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J. C., et al. The human gene for the vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947–54
   PubMed Web of Science ®Google Scholar
• Vincenti V., Caterina C., Rocchi M., Persico M. Assignment of the vascular endothelial growth factor gene to human chromosome 6P21.3. Circulation 1996; 93: 1493–5
   PubMed Web of Science ®Google Scholar
• Shahbazi M., Fryer A. A., Pravica V., Brogan I. J., Ramsay H. M., Hutchinson I. V., et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13: 260–4
   PubMed Web of Science ®Google Scholar
• Semenza G. L. Surviving ischaemia: adaptive responses mediated by hypoxia‐inducible factor 1. J Clin Invest 2000; 106: 809–12
   PubMed Web of Science ®Google Scholar